Day: July 28, 2021

MONTREAL and SARASOTA, Fla., July 28, 2021 (GLOBE NEWSWIRE) —DATE:   Wednesday, August 11th, 2021TIME:   10:00 A.M. (Eastern Time)DIAL-IN #:   877-291-4570 (USA & Canada)DIAL-IN#:   647-788-4919 (International)AN ACCOMPANYING PRESENTATION WILL ALSO BE AVAILABLE. DETAILS FOR ACCESS WILL BE INCLUDED IN THE SECOND QUARTER PRESS RELEASE. CONFERENCE CALL WILL BE AVAILABLE BY WEBCAST Click on following link to pre-register https://onlinexperiences.com/Launch/QReg/ShowUUID=6A7A20F4-0767-4759-A0AF-CD775FAED50E DIGITIZED REPLAYDIAL-IN #:   800-585-8367 (USA & Canada)DIAL-IN #:   416-621-4642 (International)ACCESS CODE:    5286215SCHEDULE:   August 11 @ 1h00 p.m. ending September 11 @ 11:59 p.m. E.T.SECOND QUARTER RESULTS WILL BE PUBLISHED BEFORE MARKET OPENS, AUGUST 11 THROUGH GLOBENEWSWIRE. For...

NEW YORK, July 28, 2021 (GLOBE NEWSWIRE) — StepStone Group Inc. (Nasdaq: STEP) today announced that Scott Hart, Co-CEO, and Mike McCabe, Head of Strategy, will present at the UBS Financial Services Virtual Conference on Wednesday, August 11, 2021 at 11:00 am ET. A live webcast and replay will be accessible through the StepStone website at https://shareholders.stepstonegroup.com. About StepStone StepStone Group Inc. (Nasdaq: STEP) is a global private markets investment firm focused on providing customized investment solutions and advisory and data services to its clients. As of March 31, 2021, StepStone oversaw approximately $427 billion of private markets allocations, including $86 billion of assets under management. StepStone’s clients include some of the world’s largest public and private defined benefit and defined contribution...

AUSTIN, Texas, July 28, 2021 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that its President and CEO, Glenn Mattes, will be available for one-on-one meetings and will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday, August 9, 2021 at 2:00pm EST. BTIG Virtual Biotechnology Conference – August 9-10, 2021 If you are interested in arranging a one-on-one meeting, please contact your BTIG conference representative. Live Link: To listen to the live event, please contact your BTIG representative. About TFF PharmaceuticalsTFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company...

ATLANTA, July 28, 2021 (GLOBE NEWSWIRE) — Manhattan Associates Inc. (NASDAQ: MANH) today announced that C&A, one of the world’s leading fashion retailers, has chosen to implement Manhattan Active® Warehouse Management across its five Brazilian distribution centers by 2022. This rollout started at C&A’s ecommerce fulfillment center in São Paulo, which went live this year, and will initially help the retailer manage its rapidly growing online business. C&A is a leading fashion retail brand with locations across 21 countries. For generations, the retailer has excelled in offering affordable clothing in the latest styles and fashion. It opened its Brazilian operations in 1976 and is now serving millions of customers a week across more than 300 stores. After experiencing a 300% growth in its ecommerce business in 2020,...

WATERTOWN, Mass., July 28, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, August 4, 2021 to report its second quarter 2021 financial results and discuss recent business highlights. To access the live conference call, please dial (877)-312-7507 (domestic) or (631)-813-4828 (international) and reference conference ID 1861354. A live audio webcast of the event can be accessed via the Investors section of the Company website at www.eyepointpharma.com. A webcast replay will also be available on the corporate website at the conclusion of the call. About EyePoint Pharmaceuticals EyePoint...

LONDON, UNITED KINGDOM , July 28, 2021 (GLOBE NEWSWIRE) — Tekcapital Plc (AIM: TEK, OTCQB: TEKCF), the UK intellectual property investment group focused on transforming university discoveries into valuable products to improve quality of life, announces that the Company will be holding a live Skyline Signature Series webinar to update investors on the business, hosted by Chief Executive Officer Clifford M. Gross, Ph.D.. Tekcapital will be the sole company presenting. The Skyline Signature Series provides public companies with a convenient and effective forum to communicate their story to a diverse audience of financial professionals through live webinars. The event will commence at 11am Eastern Time on Tuesday 3rd August 2021. Further details of the event, along with a registration form, are available here: Skyline Signature Series...

Integration of FactSet ESG data will allow new ESG screening for portfolio construction in Smartplus’ Wealth Wing platform for retail clients NORWALK, Conn. and TOKYO, July 28, 2021 (GLOBE NEWSWIRE) — FactSet (“FactSet” or the “Company”) (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading service, and Smartplus, a leading Japanese wealth management and insurance platform, today announced the integration of FactSet’s Truvalue Labs ESG content into Smartplus’ platform for retail clients. This integration will help Smartplus become the first robo-advisor investment platform in Japan that allows individual investors to consider ESG factors when selecting stocks. Smartplus, a member of Finatext Holdings, Ltd., started its investment management business...

CRESSKILL, N.J. and JERUSALEM, July 28, 2021 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its second quarter 2021 financial results as well as operational highlights before the open of the U.S. financial markets on Wednesday, August 11, 2021. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations. Conference Call Dial-In & Webcast Information:Date: Wednesday, August 11, 2021Time: 8:30 AM Eastern TimeUnited States: 877-407-3982International: 201-493-6780Conference ID: 13722002Webcast: http://public.viavid.com/index.php?id=146013The conference...

DUNMORE, Pa., July 28, 2021 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary, The Fidelity Deposit and Discount Bank, announced its most recent dividend declaration and unaudited, consolidated financial results for the three and six month periods ended June 30, 2021. Dividend Declared The Board of Directors of Fidelity D & D Bancorp, Inc. (the “Company”) announced their declaration of the Company’s third quarter dividend of $0.30 per share to shareholders of record at the close of business on August 20, 2021, payable September 10, 2021. Unaudited Financial Information Net income for the three months ended June 30, 2021 was $5.7 million, or $1.13 diluted earnings per share, compared to $0.3 million, or $0.05 diluted earnings per share, for the three months ended June 30, 2020. The...

PARAMOUNT, Calif., July 28, 2021 (GLOBE NEWSWIRE) — Tattooed Chef, Inc. (Nasdaq: TTCF) (“Tattooed Chef” or the “Company”), a leader in plant-based foods, today announced it will report financial results for the second quarter ended June 30, 2021 on Thursday, August 12, 2021 after market close. The Company will host a conference call to discuss the results at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). Investors interested in participating in the live call can dial 877-300-8521 from the U.S. and 412-317-6026 internationally. A telephone replay will be available approximately two hours after the call concludes through Thursday, August 26, 2021, and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 internationally, and entering the confirmation ID 10159081. The call will be webcast and available on the Investors...